Spineway (FRA:37S) ROCE %: -8.10% (As of Dec. 2025)


FRA:37S Spineway FRA:37S
44 GF Score
Price €0.11
GF Value €197.22
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Spineway ROCE %?

Spineway FRA:37S -1.65% 44 ROCE % is -8.10% as of Dec. 2025. GuruFocus rates FRA:37S with a GF Score™ of 44/100 and a GF Value™ of €197.22 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Spineway's annualized ROCE % for the quarter that ended in Dec. 2025 was -8.10%.

Spineway  (FRA:37S) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Spineway ROCE % Related Terms

Spineway ROCE % Historical Data

* Premium members only.

The historical data trend for Spineway's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spineway ROCE % Chart

Spineway Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.37 -12.75 -27.64 -15.83 -9.02

Spineway Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.46 -6.94 -24.31 -10.33 -8.10
FRA:37S
44GF Score
Spineway FRA:37S
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spineway ROCE % Calculation

Spineway's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-2.311/( ( (30.408 - 4.22) + (29.464 - 4.435) )/ 2 )
=-2.311/( (26.188+25.029)/ 2 )
=-2.311/25.6085
=-9.02 %

Spineway's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-2.006/( ( (30.203 - 5.719) + (29.464 - 4.435) )/ 2 )
=-2.006/( ( 24.484 + 25.029 )/ 2 )
=-2.006/24.7565
=-8.10 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -8.10% mean?
Spineway (FRA:37S) has a ROCE % of -8.10% as of Dec. 2025.
Is Spineway's ROCE % too high?
Spineway's current ROCE % is -8.10%. Overall, Spineway has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Spineway's ROCE % compare to ISRG and BDX?
Spineway's ROCE % of -8.10% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spineway's current ROCE % is -8.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineway stock overvalued right now?
Based on GuruFocus' analysis, Spineway (FRA:37S) is currently considered Possible Value Trap. The stock's GF Value™ is €197.22, compared to a current price of €0.11 — trading 99.9% below its estimated fair value. The current ROCE % is -8.10%. Spineway's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Spineway (FRA:37S), the current ROCE % is -8.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spineway (FRA:37S) Overvalued in 2026?

Based on GuruFocus' analysis, Spineway stock appears to be undervalued. The current stock price of €0.11 is trading 99.9% below its estimated GF Value™ of €197.22. GuruFocus considers Spineway to be Possible Value Trap.

Key valuation signals for FRA:37S:

  • ROCE %: -8.10%
  • GF Value™: €197.22 vs. price of €0.11 (99.9% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the FRA:37S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spineway Business Description

Other Exchanges ALSPW:France
Address 7 Allee Moulin Berger, Ecully, FRA, 69130
Spineway designs produce and markets implant lines and ancillary surgical equipment used for the treatment of severe disorders of the spinal column. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, and other such medical instruments.
44GF Score

Get the complete analysis for FRA:37S

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€197.22
GF Value